DIAMOND SPONSORS
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
PLATINUM SPONSOR
Hikma helps put better health within reach every day for millions of people around the world. For more than 45 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across North America, the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 9,400 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com
GOLD SPONSORS
Headquartered in New Brunswick, New Jersey, US; and with more than 138,000 employees and 64 manufacturing facilities across the globe, we at Johnson & Johnson are focused on elevating the standard of care – innovating at the forefront of science and technology. We use our size, scale, and diversity to change lives and communities, advancing equitable health, and putting better health within reach of all. We are innovation focused; with $17.2 billion invested in research and development across our company in 2024. We also deployed, announced, or committed over $32 billion in strategic value-creating inorganic growth opportunities in the last 12 months that further strengthen our portfolio. Together, we stand as committed and compassionate partners throughout the journey of life.
SILVER SPONSORS
SUPPORTERS
EXHIBITOR
Copyright @5th Annual International Oncology Forum. All rights reserved.